PAX4 and diabetes mellitus: To evaluate the overall impact of diabetes-associated PAX4 gene variants on the global transcriptome of human pancreatic cells, RNA-seq was performed on PAX4 variant carrier donor-derived hiPSCs across four differentiation time points using Protocol B: hiPSCs, PP2 cells, EPs and SC-islets (Supplementary Data 3).